Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Mastocytosis × Cladribine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 2 Myelodysplastic Syndromes 1 Mastocytosis, Systemic 1 Mastocytosis 1 Mast Cell Activation Disorders 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid 1 Leukemia, Monocytic, Acute 1 Leukemia 1

Interventions

Injections 1 Cladribine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01602939 2016-08-29

Cladribine Plus Pegylated Interpheron Alfa-2a in Systemic Mastocytosis

Hospital Virgen de la Salud

Phase 2/3 Unknown

Mast Cell Activation Disorders, Mastocytosis, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡